awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37092256-53DB5C52-DAE0-4330-BDAB-D4CAA1AF4AEA
Q37092256-53DB5C52-DAE0-4330-BDAB-D4CAA1AF4AEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37092256-53DB5C52-DAE0-4330-BDAB-D4CAA1AF4AEA
The impact of erlotinib use in non-small-cell lung cancer patients treated in a private reference general hospital and in a private cancer clinic from 2005 to 2011.
P2860
Q37092256-53DB5C52-DAE0-4330-BDAB-D4CAA1AF4AEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37092256-53DB5C52-DAE0-4330-BDAB-D4CAA1AF4AEA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a4cdf0e592c00bd9cf432aa8c23c25700bdf102
P2860
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study